<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"
	"http://www.w3.org/TR/1998/REC-html40-19980424/loose.dtd">
<html>
<head><meta http-equiv="content-type" content="text/html; charset=UTF-8">
<style type="text/css">
 table.main {}
 tr.row {}
 td.cell {}
 div.block {}
 div.paragraph {}
 .font0 { font:5pt Arial, sans-serif; }
 .font1 { font:6pt Arial, sans-serif; }
 .font2 { font:8pt Arial, sans-serif; }
 .font3 { font:11pt Arial, sans-serif; }
 .font4 { font:12pt Arial, sans-serif; }
 .font5 { font:16pt Arial, sans-serif; }
 .font6 { font:6pt Times New Roman, serif; }
 .font7 { font:26pt Times New Roman, serif; }

</style>
</head>
<body>
<p><span class="font7">J.P. Morgan</span></p>
<p><span class="font2">Asia Pacific Equity Research</span></p>
<div>
<p><span class="font1">22 April 2016</span></p>
<p><span class="font4" style="font-weight:bold;">Overweight</span></p>
<p><span class="font1">Price: HK$45.95 21 Apr 2016</span></p>
<p><span class="font1">Price Target: HK$57.00</span></p>
<p><span class="font1">PT End Date: 31 Dec 2016</span></p>
</div><br clear="all">
<p><span class="font5" style="font-weight:bold;">Al A Group Ltd (1299 HK)</span></p>
<p><span class="font3">Strong delivery (Micro &gt;&nbsp;Macro); 1Q16 New Business Value growth: +36% y/y</span></p>
<p><span class="font1">AI A Group has just released IQ 16 operational data. Despite last year’s high base (1Q15 NB V: +20% y/y). the company delivered another strong set of results largely above our optimistic NBV expectation. (1Q16 NBV growth: +36% (AER)/ +44% (CER) vs. JPMe: +15% (AER)/ +20% (CER)). The data suggests continuing solid business momentum in HK/CH/SG/MY. As investors have been concerned about the muted NBV growth outlook following: (1) HK’s weak volume growth potential. (2) adverse impact from local currency depreciation/ weak equity market movement across the region, and (3) sluggish volume recovery in TH. the company’s resilient business trend in IQ should help unwind negative investor sentiment with upward NBV consensus revision outlook for FYI6-17. We expect positive share price reaction post today’s strong data release.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font6" style="font-weight:bold;">• &nbsp;&nbsp;&nbsp;Strong IQ NBV growth (+36% y/y). </span><span class="font1">The company delivered US$578 million </span><span class="font6" style="font-weight:bold;">(+36% y/y) </span><span class="font1">of strong IQ 16 </span><span class="font6" style="font-weight:bold;">NBV </span><span class="font1">results on the back of strong volume growth (AFYP: US$ 1.103 million (+23% y/y vs. JPMe: +15% y/y) and NBV margin enhancement (51.6%, +4.8%p y/y vs. JPMe: 47%). Overall results show both strong product mix and volume growth in most of the company’s geographical region. 1) China’s strong business acceleration on the back of agency headcount increase, productivity improvement, and high quality product mix. 2) maintained strong growth in HK business with more regular protection focus from mainland Chinese customers, and 3) Malaysia’s business acceleration with higher scale largely drove NBV surprise during the quarter. Thailand’s product margin expectation and still-challenging business in Korea were also discussed. For the yearly result, we expect a similar shape of strong business development across the region gaining benefit from geographical diversification. As the company’s NBV growth largely exceeds market expectation proving strong micro exceeding macro in the region, overall upward NBV revision for FY16-18E is expected.</span></p></li>
<li>
<p><span class="font1">• &nbsp;&nbsp;&nbsp;Next datapoints for adding to longs- Monthly premium </span><span class="font6" style="font-weight:bold;">(CH/TH), 1Q16 </span><span class="font1">data </span><span class="font6" style="font-weight:bold;">(HK). </span><span class="font1">As 1Q16 NBV data shows, the company’s strong business trend remains intact. The product margin improvement following sales increase on the protection/ healthcare coverage as well as stable volume growth across the region supports the growth. As significant investor focus [on the company’s NBV growth! has shifted from using CER (constant exchange rates) rather than on AER (actual exchange rates) to monitor sustainable growth through market cycles, the periodic operational datapoint across the region looks a more relevant share price driver. Until the 1H16 result in mid-July. we advise monitoring: (1) monthly premium data in China (acceleration)/Thailand (margin recovery), (2) IQ 16 industry/company data in Hong Kong (managing volume), and (3) news update on AIA-Vitality’. the wellness program, launching in ASEAN countries. Based on FYI5 NBV. China Incomes the third largest country of the group’s NBV contribution (-15%) followed by Hong Kong (-34%) and Thailand (-17%). Strong monthly premium data trend in AIA China and continuing high growth in industry healthcare premium reporting potential for next three months are expected to work as near-term catalysts. Next, the company’s volatile share price movement from the start of the year was largely due to investors’ concern on AIA Hong Kong’s permanent volume contraction potential post China’s capital controls on the purchase of overseas insurance from Feb-16. Thus. IQ 16 industry/company data release by OCI (Office of the Commissioner of Insurance) is expected to remove investors’ concern to some degree (as we expect little business impact in the company/ industry from China’s credit card limit on mainland visitors’ HK insurance policy purchases). Third, we highlight that overall equity market index movement turned positive from the start of the year in Thailand (+11%). Malaysia (+2%). and Singapore (+3%). Given that unit-linked products are major sales items in those geographical regions, solid monthly volume recovery in AIA Thailand is also expected to support price momentum.</span></p></li>
<li>
<p><span class="font6" style="font-weight:bold;">• &nbsp;&nbsp;&nbsp;Reiterate OW. </span><span class="font1">We retain our price target of Dec-16 HK$57, derived by incorporating a multi-stage NBV growth model which yields an implied blended P/EV of 2. lx and blended new business of 19x for the group. Risks: 1) slowing NBV growth momentum; 2) longer-than-expeeled financial market volatility in Asia-ex: and 3) muted growth momentum in HK/China.</span></p></li></ul>
<p><span class="font2">T&amp;lel: AIA Group: Quarterly NBV Trend</span></p>
<table border="1">
<tr><td style="vertical-align:top;">
<p><span class="font1">U S$ in millions %,%p</span></p></td><td style="vertical-align:bottom;">
<p><span class="font1">1Q15 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2Q15 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3015 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4015 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1016 &nbsp;&nbsp;&nbsp;&nbsp;Chgq/q &nbsp;&nbsp;&nbsp;&nbsp;Chgy/y &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1Q16E &nbsp;&nbsp;&nbsp;&nbsp;Vs. Est.</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font1">NBV</span></p></td><td style="vertical-align:top;">
<p><span class="font1">425 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;534 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;552 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;687 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;578 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-16% &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;36% &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;489 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1 8%</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font1">- Growth (y/y) AFYP</span></p></td><td style="vertical-align:bottom;">
<p><span class="font1">20% &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;22% &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18% &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17% &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;36% &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19%p &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16%p &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15% &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21%p</span></p>
<p><span class="font1">983 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;895 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;936 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,177 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,103 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-13% &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23% &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,032 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7%</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font1">- Growth (y/y)</span></p>
<p><span class="font1">NBV Margin (=NBV/AFYP)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font1">7% &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0% &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-1% &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10% &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23% &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5%p &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16%p &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5% &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18%p</span></p>
<p><span class="font1">4 6.8% &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;53.4% &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;57.6% &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5 8.4% &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;51.6% &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-3%p &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5%p &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4 7.4% &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4%p</span></p></td></tr>
</table>
<p><span class="font0">Source Company reportsandJ.P. Mor^n estimates</span></p>
<p><span class="font6" style="font-weight:bold;">Investment Thesis</span></p>
<p><span class="font1">AIA Group is the leading life insurer across Asia ex-Japan, based on agency operations. For the last 90 years, the company has focused on managing its leading positions in Hong Kong. Singapore and Thailand. Low insurance penetration across the region, favorable demographic changes and household income growth (i.e.. rising GDP per capita) in China and ASEAN countries should support strong NBV growth momentum, with solid margins and volume growth as the market transforms into an agency-based protection-type market, where AIA has had a strong competitive edge for the last 90 years</span></p>
</body>
</html>